Side-by-side comparison of AI visibility scores, market position, and capabilities
Rightway is the most transparent PBM and care navigation platform for employers; delivers 16.1% lower pharmacy costs and 15% medical cost savings; launched 2025 rebrand as integrated PBM + care navigation leader.
Rightway is a healthcare benefits company that combines Pharmacy Benefits Management (PBM) and personalized care navigation in a single integrated platform for self-insured employers. Founded in 2017 and headquartered in New York City, Rightway positions itself as the most transparent and member-focused PBM in the market — operating on fully aligned, pass-through pricing with a 100% transparency model and a total pharmacy spend guarantee that traditional PBMs do not offer. The company launched a significant 2025 rebrand marking its evolution from challenger to category leader.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.